Class II โ€” Potential Health Hazard

Potential health hazard โ€” use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Venlafaxine Hydrochloride Extended-Release Capsules USP Recalled by Lucid Pharma LLC Due to Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing...

Date: June 1, 2017
Company: Lucid Pharma LLC
Status: Terminated
Source: FDA (Drug)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Lucid Pharma LLC directly.

Affected Products

Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.

Quantity: a) 44168 bottles; b) 24960 bottles

Why Was This Recalled?

Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Lucid Pharma LLC

Lucid Pharma LLC has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report